Man, 61, dies after large chain necklace pulls him into MRI machine
Article content
The man, 61, had entered an MRI room while a scan was underway Wednesday afternoon at Nassau Open MRI. The machine's strong magnetic force drew him in by his metallic necklace, according to a release from the Nassau County Police Department.
Article content
Article content
Article content
He died Thursday afternoon, but a police officer who answered the phone at the Nassau County police precinct where the MRI facility is located said the department had not been given permission to release the name Saturday.
Article content
Article content
Adrienne Jones-McAllister told News 12 Long Island in a recorded interview that she was undergoing an MRI on her knee when she asked the technician to get her husband, Keith McAllister, to help her get off the table.
Article content
When he got close to her, she said, 'at that instant, the machine switched him around, pulled him in and he hit the MRI.'
Article content
'I said: 'Could you turn off the machine, call 911, do something, Turn this damn thing off!'' she recalled, as tears ran down her face. 'He went limp in my arms.'
Article content
She told News 12 that the technician summoned into the room her husband, who was wearing a 20-pound chain that he uses for weight training, an object they'd had a casual conversation about during a previous visit.
Article content
Article content
'He waved goodbye to me and then his whole body went limp,' Jones-McAllister told the TV outlet.
Article content
Article content
A person who answered the phone at Nassau Open MRI on Long Island declined to comment Friday. The phone number went unanswered on Saturday.
Article content
It wasn't the first New York death to result from an MRI machine.
Article content
In 2001, 6-year-old Michael Colombini of Croton-on-Hudson was killed at the Westchester Medical Center when an oxygen tank flew into the chamber, drawn in by the MRI's 10-ton electromagnet.
In 2010, records filed in Westchester County revealed that the family settled a lawsuit for $2.9 million.
Article content
MRI machines 'employ a strong magnetic field' that 'exerts very powerful forces on objects of iron, some steels, and other magnetizable objects,' according to the National Institute of Biomedical Imaging and Bioengineering, which says the units are 'strong enough to fling a wheelchair across the room.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Unlocking ROI in Medical Imaging: The Strategic Growth of the Global MRI Systems Market
"The key players profiled in the MRI systems market are Siemens Healthineers (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan), Canon Inc. (Japan), Fonar Corporation (US)" Browse 226 market data Tables and 56 Figures spread through 259 Pages and in-depth TOC on "MRI Systems Market by Architecture (Open, Closed), Field Strength (High Field MRI Systems & Low Field MRI Systems), Design (Portable MRI Systems, Fixed/Stationary MRI Systems), End User (Hospitals, Diagnostic Clinic), Region - Global Forecast to 2030 Why MRI Systems Are a Smart Long-Term Investment As the healthcare industry undergoes a paradigm shift toward precision medicine and value-based care, Magnetic Resonance Imaging (MRI) has emerged as a cornerstone of diagnostic excellence. Forecasted to grow from USD 6.15 billion in 2024 to USD 9.01 billion by 2030, the MRI systems market offers robust opportunities for healthcare providers, OEMs, and strategic investors alike. For C-level executives, the MRI market represents more than just imaging hardware—it's a long-term investment in AI-enabled diagnostics, faster clinical workflows, and improved patient outcomes. With a CAGR of 6.5%, the sector is primed for innovation-led expansion and solid ROI. Market Snapshot: A Growing Industry with Predictable ROI 2024 Market Size: USD 6.15 Billion 2025 Projection: USD 6.56 Billion 2030 Forecast: USD 9.01 Billion CAGR: 6.5% (2024–2030) Driving Forces: Rise in neurological and musculoskeletal conditions Global aging population Increasing oncology imaging requirements Advancements in ultra-high-field MRI Favorable regulatory and reimbursement environments High-Value Applications: Brain & Neurological MRI Lead the Charge According to market research, brain and neurological MRI is the largest and fastest-growing application segment. This growth is driven by the surge in neurodegenerative disorders such as Alzheimer's, Parkinson's, epilepsy, and stroke. For hospital executives and diagnostic center owners, investing in neuro-MRI systems ensures better diagnostic precision, faster patient throughput, and enhanced clinical reputation—all critical ROI levers. Key ROI Insights: Faster diagnosis → Reduced inpatient days High diagnostic accuracy → Lower misdiagnosis risk Software upgrades → Extended equipment lifecycle Field Strength Matters: Ultra-High-Field MRI Is the Future The market is categorized by field strength: Low-to-mid-field High & very-high-field Ultra-high-field Among these, ultra-high-field MRI is experiencing the highest CAGR. These systems offer: Superior Signal-to-Noise Ratio (SNR) Enhanced contrast resolution Exceptional neuro and cardiovascular imaging As hospitals seek competitive clinical differentiation, ultra-high-field MRI investments will become a strategic priority. End User Analysis: Why Hospitals Dominate the Market Hospitals are currently the largest adopters of MRI systems and are expected to continue dominating. Their edge lies in: Access to capital investment budgets Integrated multi-specialty diagnostic care Alignment with value-based reimbursement models For CFOs and CIOs, the integration of MRI into enterprise imaging architecture ensures: Optimized resource allocation Predictable revenue from advanced imaging Better data utilization for AI algorithms Geographical Insights: North America Sets the Pace North America leads the global MRI systems market due to: Cutting-edge healthcare infrastructure Strong presence of OEMs and distributors Favorable regulatory and R&D support Healthcare providers in the U.S. are focusing on: High-throughput MRI centers Remote scanning capabilities Integration with AI and cloud-based radiology tools For OEMs and med-tech investors, the region is ripe for partnerships, pilot programs, and acquisitions. Request Sample Pages : Top Companies to Watch: Strategic Moves from Market Leaders 1. Siemens Healthineers (Germany) A frontrunner with a global manufacturing and R&D footprint, Siemens has deep investments in molecular imaging, AI-driven diagnostics, and portable MRI innovations. 2. GE HealthCare (US) GE's strategic growth is powered by inorganic acquisitions and global reach. Their solutions span molecular imaging, cardiac MRI, and biopharma integration. 3. Philips (Netherlands) Philips focuses on image-guided therapy, ultrasound integration, and cloud-connected platforms. Their Diagnosis & Treatment segment is a growth engine for MRI innovation. Other notable players: Canon Inc. (Japan) FUJIFILM Corporation (Japan) Fonar Corporation (US) Esaote S.p.A (Italy) United Imaging Healthcare (China) Innovation Trends: The Future of MRI is AI, Portability & Cloud Emerging innovation themes include: AI-enhanced image reconstruction Low-helium or helium-free systems Cloud-integrated radiology reporting Portable and point-of-care MRI Strategic Implications for C-suite: AI & ML tools embedded into MRI workflows can increase operational efficiency by 20–30% Cloud PACS integration ensures interoperability across multisite locations Portability introduces new revenue streams in mobile diagnostics and remote care What This Means for Healthcare Decision-Makers For CIOs, CFOs, and Clinical Executives, investing in MRI systems is no longer about hardware—it's a holistic ecosystem decision involving software, analytics, AI, and patient experience. Key Questions Executives Are Asking: How does MRI investment impact long-term patient retention and referral growth? Can we bundle MRI services with AI diagnostics for higher margins? What's the total cost of ownership (TCO) versus projected operational ROI? Conclusion: MRI Systems as a Strategic Differentiator in 2030 As demand for advanced diagnostic capabilities surges globally, MRI systems stand out as a high-impact, high-yield investment. With expanding clinical applications, regulatory support, and innovation momentum, this is an opportunity that healthcare leaders cannot afford to overlook. Whether you're managing hospital procurement, evaluating M&A options in the imaging space, or scaling a diagnostic chain, the MRI systems market offers sustainable ROI, technological resilience, and significant growth potential through 2030. For more information, Inquire Now!
CTV News
6 hours ago
- CTV News
Trump administration weighs fate of $9M stockpile of contraceptives feared earmarked for destruction
Irene A Kerkulah, the health officer in charge at the Palala Clinic, looks at an almost-empty shelf at the clinic that once held contraceptives, in Bong County, Friday, June 13, 2025. (AP Photo/Annie Risemberg, File) BRUSSELS — President Donald Trump's administration says it is weighing what to do with family planning supplies stockpiled in Europe that campaigners and two U.S. senators are fighting to save from destruction. Concerns that the Trump administration plans to incinerate the stockpile have angered family planning advocates on both sides of the Atlantic. Campaigners say the supplies stored in a U.S.-funded warehouse in Geel, Belgium, include contraceptive pills, contraceptive implants and IUDs that could spare women in war zones and elsewhere the hardship of unwanted pregnancies. U.S. State Department deputy spokesman Tommy Pigott said Thursday in response to a question about the contraceptives that 'we're still in the process here in terms of determining the way forward.' 'When we have an update, we'll provide it,' he said. Belgium says it has been talking with U.S. diplomats about trying to spare the supplies from destruction, including possibly moving them out of the warehouse. Foreign Ministry spokesperson Florinda Baleci told The Associated Press that she couldn't comment further 'to avoid influencing the outcome of the discussions.' The Trump administration's dismantling of the U.S. Agency for International Development, which managed foreign aid programs, left the supplies' fate uncertain. Pigott didn't detail the types of contraceptives that make up the stockpile. He said some of the supplies, bought by the previous administration, could 'potentially be' drugs designed to induce abortions. Pigott didn't detail how that might impact Trump administration thinking about how to deal with the drugs or the entire stockpile. Costing more than US$9 million and funded by U.S taxpayers, the family planning supplies were intended for women in war zones, refugee camps and elsewhere, according to a bipartisan letter of protest to U.S. Secretary of State Marco Rubio from U.S. senators Jeanne Shaheen, a New Hampshire Democrat, and Alaska Republican Lisa Murkowski. They said destroying the stockpile 'would be a waste of U.S. taxpayer dollars as well as an abdication of U.S. global leadership in preventing unintended pregnancies, unsafe abortions and maternal deaths — key goals of U.S. foreign assistance.' They urged Rubio to allow another country or partner to distribute the contraceptives. Concerns voiced by European campaigners and lawmakers that the supplies could be transported to France for incineration have led to mounting pressure on government officials to intervene and save them. The executive branch of the European Union, through spokesman Guillaume Mercier, said Friday that 'we continue to monitor the situation closely to explore the most effective solutions.' The U.S. branch of family planning aid group MSI Reproductive Choices said it offered to purchase, repackage and distribute the stock at its own expense but 'these efforts were repeatedly rejected.' The group said the supplies included long-acting IUDs, contraceptive implants and pills, and that they have long shelf-lives, extending as far as 2031. Aid group Doctors Without Borders said incineration would be 'an intentionally reckless and harmful act against women and girls everywhere.' Charles Dallara, the grandson of a French former lawmaker who was a contraception pioneer in France, urged President Emmanuel Macron to not let France 'become an accomplice to this scandal.' 'Do not allow France to take part in the destruction of essential health tools for millions of women,' Dallara wrote in an appeal to the French leader. 'We have a moral and historical responsibility.' ___ Leicester reported from Paris. Matthew Lee contributed from Washington, D.C. Lorne Cook And John Leicester, The Associated Press
Toronto Star
7 hours ago
- Toronto Star
EU chief's texts to a pharma boss during pandemic were likely erased, the NYT reports
BRUSSELS (AP) — Text messages exchanged between European Commission President Ursula von der Leyen and a pharmaceutical boss during the COVID-19 pandemic were seen by her top adviser and have likely been destroyed, the New York Times reported Friday. Von der Leyen and Pfizer CEO Albert Bourla exchanged the messages as COVID-19 ravaged European communities from Portugal to Finland and the EU scrambled to buy millions of hard to find vaccines. She was under intense scrutiny to deliver.
